PHARMA - June 2019
Provider: OA National Provider
Contact: Optometry Australia OA Provider, [E] s.hanna@optometry.org.au, [P] 96688550
Learning Objectives
- gain an understanding on the functional vision loss experienced by patients with ring scotomas due to AMD and how to manage such patients
- become more familiar with the various peripheral retinal changes that occur in AMD and how these can be detected
- become more familiar with the ocular conditions optometrists usually experience and challenges faced in domiciliary eye care
- become more familiar with the factors associated with anti-VEGF therapy in the treatment of neovascular AMD
- gain an understanding of the clinical classification of AMD
- become more familiar with the evidence-based modifiable lifestyle risk factors associated with AMD
- become more familiar with the LEAD trial and the potential role of nanosecond laser treatment for AMD
- become more familiar with the use of OCT in the investigation of various systemic neurologic disease
- gain an understanding of how to differentiate macular dystrophies from AMD
- gain an understanding of the support and services provided by low vision providers and when it may be appropriate to refer patients to such providers
Max points awarded: 6.00
Session Information
| Name |
|---|
| PHARMA - June 2019 |
| Activity Type |
| Independent Learning with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 5.00 |
| Name |
|---|
| PHARMA - June 2019 |
| Activity Type |
| Independent Learning with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
|---|---|---|---|---|
| PHARMA - June 2019 | Independent Learning with Assessment | No | No | 5.00 |
| PHARMA - June 2019 | Independent Learning with Assessment | Yes | No | 1.00 |